Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.464 Q1 | 82 | 11 | 40 | 2379 | 229 | 40 | 4.88 | 216.27 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 5.545 Q1 | 70 | 10 | 40 | 2129 | 395 | 40 | 10.18 | 212.90 | |
3 | Pharmacological Reviews | journal | 9.872 Q1 | 254 | 30 | 73 | 5479 | 1707 | 71 | 16.30 | 182.63 | |
4 | Pharmacology and Therapeutics | journal | 3.888 Q1 | 233 | 85 | 183 | 14160 | 1752 | 180 | 9.45 | 166.59 | |
5 | Infectious Disorders - Drug Targets | journal | 0.992 Q1 | 61 | 31 | 94 | 4786 | 277 | 87 | 2.64 | 154.39 | |
6 | Current Neuropharmacology | journal | 0.505 Q3 | 103 | 23 | 32 | 3390 | 42 | 30 | 1.31 | 147.39 | |
7 | CNS and Neurological Disorders - Drug Targets | journal | 2.095 Q1 | 96 | 63 | 126 | 9179 | 723 | 123 | 5.00 | 145.70 | |
8 | Annual Review of Pharmacology and Toxicology | journal | 10.789 Q1 | 224 | 29 | 71 | 4036 | 1677 | 71 | 22.75 | 139.17 | |
9 | Current Medicinal Chemistry | journal | 1.709 Q1 | 202 | 184 | 560 | 24924 | 2846 | 526 | 5.20 | 135.46 | |
10 | Current Cancer Drug Targets | journal | 2.351 Q1 | 103 | 49 | 112 | 6470 | 650 | 109 | 5.93 | 132.04 | |
11 | Medicinal Research Reviews | journal | 2.935 Q1 | 150 | 29 | 80 | 3798 | 789 | 80 | 9.22 | 130.97 | |
12 | Current Pharmaceutical Design | journal | 1.647 Q1 | 183 | 314 | 799 | 38219 | 3835 | 697 | 4.89 | 121.72 | |
13 | Expert Opinion on Therapeutic Targets | journal | 0.999 Q1 | 106 | 89 | 169 | 10586 | 417 | 159 | 2.62 | 118.94 | |
14 | Expert Opinion on Emerging Drugs | journal | 0.570 Q2 | 54 | 53 | 88 | 6214 | 194 | 86 | 2.83 | 117.25 | |
15 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.425 Q1 | 108 | 47 | 129 | 5410 | 529 | 122 | 3.39 | 115.11 | |
16 | Current Drug Metabolism | journal | 1.926 Q1 | 122 | 42 | 120 | 4777 | 773 | 114 | 6.16 | 113.74 | |
17 | Current Pharmacogenomics | journal | 0.224 Q3 | 12 | 24 | 32 | 2670 | 25 | 32 | 0.78 | 111.25 | |
18 | Anti-Infective Agents | journal | 0.322 Q3 | 26 | 23 | 24 | 2527 | 27 | 22 | 1.13 | 109.87 | |
19 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.611 Q2 | 43 | 38 | 53 | 4157 | 119 | 53 | 2.25 | 109.39 | |
20 | Progress in Medicinal Chemistry | journal | 1.045 Q1 | 38 | 8 | 26 | 868 | 80 | 22 | 2.67 | 108.50 | |
21 | Current Drug Targets | journal | 1.451 Q1 | 119 | 92 | 172 | 9901 | 730 | 160 | 4.40 | 107.62 | |
22 | Drug Resistance Updates | journal | 2.708 Q1 | 132 | 29 | 87 | 3075 | 606 | 82 | 6.79 | 106.03 | |
23 | Current Drug Targets: Inflammation and Allergy | journal | 1.265 Q1 | 53 | 88 | 110 | 9313 | 358 | 106 | 2.74 | 105.83 | |
24 | Neurotherapeutics | journal | 0.712 Q2 | 136 | 58 | 51 | 5904 | 131 | 45 | 2.57 | 101.79 | |
25 | Expert Opinion on Drug Metabolism and Toxicology | journal | 100 | 51 | 0 | 5082 | 0 | 0 | 0.00 | 99.65 | ||
26 | Current Vascular Pharmacology | journal | 0.869 Q2 | 69 | 42 | 70 | 4147 | 156 | 70 | 2.23 | 98.74 | |
27 | American Journal of Drug Delivery | journal | 0.344 Q3 | 23 | 21 | 20 | 2033 | 16 | 20 | 0.80 | 96.81 | |
28 | Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents | journal | 11 | 64 | 36 | 5982 | 12 | 32 | 0.33 | 93.47 | ||
29 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.678 Q2 | 45 | 52 | 71 | 4786 | 125 | 65 | 1.90 | 92.04 | |
30 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.135 Q4 | 27 | 70 | 31 | 6427 | 13 | 28 | 0.42 | 91.81 | |
31 | Mini-Reviews in Medicinal Chemistry | journal | 0.828 Q2 | 107 | 99 | 224 | 8937 | 621 | 215 | 2.78 | 90.27 | |
32 | Cellular and Molecular Life Sciences | journal | 2.691 Q1 | 261 | 271 | 707 | 24423 | 3766 | 702 | 4.94 | 90.12 | |
33 | BioDrugs | journal | 0.649 Q2 | 79 | 35 | 137 | 3137 | 357 | 133 | 2.30 | 89.63 | |
34 | Expert Opinion on Biological Therapy | journal | 0.943 Q1 | 102 | 140 | 378 | 11936 | 1061 | 365 | 2.90 | 85.26 | |
35 | Expert Opinion on Investigational Drugs | journal | 1.059 Q1 | 117 | 137 | 423 | 11445 | 1588 | 412 | 3.61 | 83.54 | |
36 | Advances in Pharmacology | journal | 0.205 Q3 | 86 | 20 | 34 | 1519 | 12 | 32 | 0.35 | 75.95 | |
37 | Clinical Pharmacokinetics | journal | 1.745 Q1 | 184 | 86 | 248 | 6300 | 1723 | 245 | 7.12 | 73.26 | |
38 | Expert Review of Vaccines | journal | 0.801 Q2 | 105 | 82 | 240 | 5937 | 592 | 220 | 2.60 | 72.40 | |
39 | Drug Safety | journal | 1.053 Q1 | 140 | 86 | 272 | 5982 | 1158 | 258 | 4.11 | 69.56 | |
40 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 242 | 594 | 16676 | 1479 | 582 | 2.47 | 68.91 | |
41 | Molecular Diagnosis and Therapy | journal | 68 | 61 | 161 | 4159 | 452 | 159 | 2.90 | 68.18 | ||
42 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 50 | 155 | 3354 | 3 | 155 | 0.03 | 67.08 | |
43 | CNS Drug Reviews | journal | 0.791 Q2 | 64 | 27 | 71 | 1777 | 207 | 69 | 3.16 | 65.81 | |
44 | Toxicological Reviews | journal | 0.737 Q2 | 49 | 29 | 46 | 1862 | 109 | 45 | 2.37 | 64.21 | |
45 | Cardiovascular Drug Reviews | journal | 0.646 Q2 | 54 | 24 | 74 | 1540 | 176 | 74 | 2.20 | 64.17 | |
46 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.111 Q4 | 29 | 23 | 19 | 1464 | 4 | 19 | 0.00 | 63.65 | |
47 | Current Opinion in Investigational Drugs | journal | 0.921 Q2 | 83 | 148 | 571 | 8853 | 1617 | 531 | 3.06 | 59.82 | |
48 | Core Evidence (discontinued) | journal | 29 | 12 | 0 | 708 | 0 | 0 | 0.00 | 59.00 | ||
49 | Drugs of Today | journal | 0.517 Q2 | 57 | 76 | 243 | 4444 | 469 | 242 | 1.98 | 58.47 | |
50 | Neuropsychopharmacology | journal | 2.583 Q1 | 249 | 238 | 727 | 13808 | 4232 | 688 | 5.53 | 58.02 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®